Project Grant HT9425261E211
Award Date 9/30/26
Completion Date 6/29/28
Dollars Obligated $500K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- Federal Project Grant Award Summary The University of Pennsylvania received a $812,487 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, with an ultimate completion date of September 29, 2028. The award supports research titled "Modulating Liver Inflammation to Improve Outcomes in Pancreatic Cancer," to be conducted at the university's Philadelphia campus. Under this three-year...
- Federal Grant Award Summary The University of Pennsylvania received a $581,220 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. The award supports research titled "Accelerating Post-Traumatic Epilepsy Research Through Data Integration and Verifiable Analysis at Scale," which will be conducted in Philadelphia, Pennsylvania. This modification adds $74,588...
- The University of Pennsylvania received a $347,752 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded June 1, 2026, with completion targeted for May 31, 2027. The award supports preclinical evaluation of dual KRAS (Kirsten Rat Sarcoma) and BET (Bromodomain and Extra-Terminal protein) inhibition as a therapeutic approach in RAS-altered epithelial ovarian cancers. This research aligns with the DHA's mission to...
- Federal Grant Award Summary The University of Washington's Office of Sponsored Programs received a $498,600 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2026, through July 31, 2028. The grant supports research investigating anti-dystrophin T cell responses in patients with Duchenne muscular dystrophy (DMD), a progressive genetic muscle disorder affecting the military-relevant population....
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded University of Pennsylvania $981,386 under the Military Medical Research and Development program (CFDA 12.420) for a three-year project titled "Daytime Point-of-Care Carbon Dioxide Monitoring in ALS" (July 1, 2026–June 30, 2029). This project grant supports research and development activities addressing amyotrophic lateral sclerosis (ALS), a neurodegenerative condition affecting the military population and Service...
- Federal Grant Award Summary The University of Pennsylvania received a $1,305,270 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to establish the Ovarian Cancer Academy: Advancing Ovarian Cancer Research Through Mentorship, Networking, and Collaborations. The four-year award, which commenced on September 30, 2025 and extends through September 29, 2029, will be performed at the university's Philadelphia campus. This...
- The University of Pennsylvania was awarded a $390,000 Formula Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on March 15, 2025, will fund research to exploit synthetic essential genetic dependencies to define oncogenic signaling networks and establish novel targets for lung adenocarcinoma therapy. This work aims to transform healthcare for military service members, veterans, and the broader public by developing...
- The University of Pennsylvania's Clinical Practices is the recipient of a $861,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the advancement of mechanistic understanding of autoimmunity in aplastic anemia through HLA allele specificity research. The project aims to provide critical insights that could lead to improved treatments for this medical condition, with a...
- Federal Grant Award Summary The University of Washington Office of Sponsored Programs received a $499,551 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2026, through June 30, 2028. The project, titled "Enhancing Muscle Stem Cell Targeting to Improve Durability of Genome Editing Therapies for DMD" (Duchenne muscular dystrophy), supports biomedical research addressing Service Member health...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $676,117 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025, with completion scheduled for August 31, 2029. The research project focuses on expanded GAA-GGA chimeric repeats in Friedreich Ataxia, a rare neurological genetic disorder. This award supports biomedical research aimed at advancing medical...